Logo image of MDX.CA

MEDX HEALTH CORP (MDX.CA) Stock Fundamental Analysis

TSX-V:MDX - TSX Venture Exchange - CA5850901037 - Common Stock - Currency: CAD

0.065  0 (0%)

Fundamental Rating

0

MDX gets a fundamental rating of 0 out of 10. The analysis compared the fundamentals against 14 industry peers in the Health Care Equipment & Supplies industry. MDX may be in some trouble as it scores bad on both profitability and health. MDX does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

MDX had negative earnings in the past year.
MDX had a negative operating cash flow in the past year.
MDX had negative earnings in each of the past 5 years.
In the past 5 years MDX always reported negative operating cash flow.
MDX.CA Yearly Net Income VS EBIT VS OCF VS FCFMDX.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -1M -2M -3M -4M -5M

1.2 Ratios

The Return On Assets of MDX (-547.17%) is worse than 92.86% of its industry peers.
Industry RankSector Rank
ROA -547.17%
ROE N/A
ROIC N/A
ROA(3y)-597.39%
ROA(5y)-591.2%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MDX.CA Yearly ROA, ROE, ROICMDX.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 -400 -600

1.3 Margins

MDX has a Gross Margin (42.53%) which is in line with its industry peers.
In the last couple of years the Gross Margin of MDX has declined.
MDX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 42.53%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.51%
GM growth 5Y-6.59%
MDX.CA Yearly Profit, Operating, Gross MarginsMDX.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800 -1K

More info and screens

0

2. Health

2.1 Basic Checks

MDX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for MDX has been increased compared to 1 year ago.
MDX has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, MDX has an improved debt to assets ratio.
MDX.CA Yearly Shares OutstandingMDX.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
MDX.CA Yearly Total Debt VS Total AssetsMDX.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M

2.2 Solvency

MDX has an Altman-Z score of -118.70. This is a bad value and indicates that MDX is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of MDX (-118.70) is worse than 85.71% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -118.7
ROIC/WACCN/A
WACC7.59%
MDX.CA Yearly LT Debt VS Equity VS FCFMDX.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M -4M -6M -8M

2.3 Liquidity

A Current Ratio of 0.08 indicates that MDX may have some problems paying its short term obligations.
The Current ratio of MDX (0.08) is worse than 85.71% of its industry peers.
MDX has a Quick Ratio of 0.08. This is a bad value and indicates that MDX is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.04, MDX is doing worse than 92.86% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.08
Quick Ratio 0.04
MDX.CA Yearly Current Assets VS Current LiabilitesMDX.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M

More info and screens

0

3. Growth

3.1 Past

MDX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 23.33%, which is quite impressive.
MDX shows a decrease in Revenue. In the last year, the revenue decreased by -3.93%.
The Revenue for MDX have been decreasing by -10.66% on average. This is quite bad
EPS 1Y (TTM)23.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-68.57%
Revenue 1Y (TTM)-3.93%
Revenue growth 3Y-4.55%
Revenue growth 5Y-10.66%
Sales Q2Q%4.03%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MDX.CA Yearly Revenue VS EstimatesMDX.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M
MDX.CA Yearly EPS VS EstimatesMDX.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 -0 -0 -0.01 -0.01 -0.01

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MDX. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MDX.CA Price Earnings VS Forward Price EarningsMDX.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MDX.CA Per share dataMDX.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.01 -0.02 -0.03

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MDX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MEDX HEALTH CORP

TSX-V:MDX (7/31/2025, 7:00:00 PM)

0.065

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)06-02 2025-06-02
Earnings (Next)08-20 2025-08-20
Inst Owners0.01%
Inst Owner ChangeN/A
Ins Owners28.11%
Ins Owner ChangeN/A
Market Cap19.62M
Analysts84.44
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 39.71
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.02
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS-0.03
TBVpS-0.03
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -547.17%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 42.53%
FCFM N/A
ROA(3y)-597.39%
ROA(5y)-591.2%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.51%
GM growth 5Y-6.59%
F-Score4
Asset Turnover0.63
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.08
Quick Ratio 0.04
Altman-Z -118.7
F-Score4
WACC7.59%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)23.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-68.57%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-3.93%
Revenue growth 3Y-4.55%
Revenue growth 5Y-10.66%
Sales Q2Q%4.03%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y8.19%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y21.78%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y21.78%
OCF growth 3YN/A
OCF growth 5YN/A